IntraLase Corp.

U.S. FDA expands FS30 laser use to include Keratoplasty corneal resections

Published in Lab Business Week, October 9th, 2005

IntraLase Corp. (ILSE) announced that it has received a new 510(k) clearance from the U.S. Food & Drug Administration (FDA) for use of the IntraLase FS30 femtosecond laser in creating the corneal resections performed in lamellar keratoplasty and penetrating keratoplasty procedures.

The IntraLase FS30 laser is the first and only laser to receive clearance for use in penetrating keratoplasty, according to the company.

For the first time surgeons can use the power and precision of the laser to complete resections in a wide variety of corneal therapeutic applications. The new clearance allows use of the IntraLase FS30 laser to create deep corneal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-10-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry